Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: Potential role of protein Z as a powerful determinant of coagulation assays-Reference-Cited by-同舟云学术

Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: Potential role of protein Z as a powerful determinant of coagulation assays

Published:2013-07 Issue:1 Volume:132 Page:e70-e75
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Choi Qute,Kim Ji-Eun,Hyun Jungwon,Han Kyou-Sup,Kim Hyun Kyung

Funder

Ministry of Education, Science and Technology

Publisher

Elsevier BV

Subject

Hematology

Reference17 articles.

1. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Ansell;Chest,2008

2. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment;D'Angelo;Haematologica,2002

3. Thrombin generation assay and other universal tests for monitoring haemophilia therapy;Varadi;Haemophilia,2004

4. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?;Salvagno;Haemophilia,2009

5. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation;Gatt;Br J Haematol,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warfarin-Induced Skin Necrosis Mimicking as Acute Limb Ischemia: a Surgical Conundrum;Indian Journal of Surgery;2023-11-03

2. Comparison of the International Normalized Ratio Between a Point-of-Care Test and a Conventional Laboratory Test: the Latter Performs Better in Assessing Warfarin-induced Changes in Coagulation Factors;Annals of Laboratory Medicine;2023-02-24

3. Prothrombin Complex Concentrates to Treat Coagulation Disturbances: An Overview With a Focus on Use in Infants and Children;Cardiology Research;2022-02

4. Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban;Journal of Thrombosis and Thrombolysis;2020-05-06

5. CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients;The Pharmacogenomics Journal;2020-02-06